Home Print this page Email this page Users Online: 323
Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
Year : 2022  |  Volume : 10  |  Issue : 1  |  Page : 19-24

External validation of 4C ISARIC mortality score in critically ill COVID-19 patients from Saudi Arabia

1 Critical Care Department, King Saud Medical City, Australia
2 Critical Care Department, The Wollongong Hospital, NSW, Australia
3 Critical Care Department, King Saud Medical City; Anesthesia Department, Faculty of Medicine, Tanta University, Tanta, Egypt
4 College of Medicine, Alfaisal University, Riyadh, Saudi Arabia
5 Internal Medicine Department, Prince Mohammed Bin Abdulaziz Hospital, Riyadh, Saudi Arabia

Correspondence Address:
Waleed Tharwat Aletreby
Critical Care Department, King Saud Medical City, Riyadh
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/sjmms.sjmms_480_21

Rights and Permissions

Background: ISARIC mortality score is a risk stratification tool that helps predict the in-hospital mortality of COVID-19 patients. However, this tool was developed and validated in a British population, and thus, the external validation of this tool in local populations is important. Objectives: External validation of the ISARIC mortality score in COVID-19 patients from a large Saudi Arabian intensive care unit (ICU). Methods: This is a retrospective study that included all adult patients with COVID-19 admitted to the ICU of King Saud Medical City, Riyadh, Saudi Arabia, from March 2020 to June 2021. Patients who were pregnant or had pulmonary tuberculosis/human immunodeficiency virus were excluded along with patients with missing variables. Data were collected to calculate the ISARIC mortality score and then fitting receiver operator characteristic curve against patients' outcome. Results: A total of 1493 critically ill COVID-19 patients were included. The mortality was 38%, the area under the curve of the score was 0.81 (95% confidence interval [CI]: 0.79–0.83, P < 0.001) and the cutoff value correctly classified 72.7% of the cohort. The cutoff value of >9 had sensitivity of 70.5% (95% CI: 66.6–74.3); specificity, 73.97% (95% CI: 71–76.8); positive predictive value, 62.4% (95% CI: 59.5–65.2) and negative predictive value, 80.2% (95% CI: 78.2–82.4). Conclusion: The ISARIC score was found to have excellent predictive ability for mortality in critically ill COVID-19 patients in our Saudi Arabian cohort. A cutoff score of >9 was the optimal criterion.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded465    
    Comments [Add]    

Recommend this journal